IBS

Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company specializing in non-invasive, rapid, and high-accuracy testing solutions. The company's flagship product is the Intelligent Fingerprinting Drug Screening System, which analyzes sweat from fingerprints to detect recent drug use—including opiates, cocaine, methamphetamine, and cannabis—in under ten minutes. This portable and hygienic platform is primarily used by employers in safety-critical industries such as construction, transport, and manufacturing, as well as by drug treatment organizations and coroners. Headquartered in New York, the company is expanding globally and is currently pursuing FDA 510(k) clearance for the U.S. market. Beyond drug screening, the company is developing a proprietary biosensor platform for future diagnostic applications in chronic disease management, such as glucose and hormone monitoring. With over 500,000 tests sold internationally, the company operates a recurring revenue model based on the sale of consumable test cartridges.